02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HEPATOLOGY, VOLUME 62, NUMBER 1 (SUPPL) AASLD ABSTRACTS 675A<br />

947<br />

Adipose tissue-derived stromal cells preventatively suppressed<br />

pathological progression of murine non-alcoholic<br />

steatohepatitis model.<br />

Masatoshi Yamato 1,2 , Yoshio Sakai 1 , Hatsune Mochida 2 , Akihiro<br />

Seki 2 , Kosuke Ishida 2 , Masao Honda 2,1 , Shuichi Kaneko 2,1 ; 1 Gastoroenterology,<br />

Kanazawa University, Kanazawa, Japan; 2 Disease<br />

Control and Homeostasis, Kanazawa University, Kanazawa,<br />

Japan<br />

Non-alcoholic steatohepatitis (NASH) is characterized by steatosis<br />

in hepatocytes accompanied with persisting inflammation,<br />

developing fibrosis to ultimate cirrhosis. The pathogenesis<br />

of NASH is not fully elucidated, and the fundamental treatment<br />

of NASH is yet to be established. We previously reported that<br />

ADSCs are therapeutically beneficial as being functionally and<br />

histologically repairable of the end-stage cirrhotic mice caused<br />

by NASH. In this study, we analyzed pathological progression<br />

of NASH mice model and succeedingly assessed how<br />

ADSC administration affected on early stage NASH disease<br />

progression.[Materials and Methods] C57Bl/6J mice (female,<br />

10 weeks old) were initiated to be fed with high fat atherogenic<br />

(HF-AT) diet to develop steatohepatitis. On week 1, 2,<br />

3, 4, 8, and 12, we obtained liver tissue samples. ADSCs<br />

were isolated from adipose tissue of C57BL/6J mice by collagenase<br />

I digestion, cultured and expanded. On week 4 and 8,<br />

ADSCs (1×10^5 ) were injected twice every 4 weeks into the<br />

splenic subcapsule, and on week 12, the liver tissue samples<br />

were obtained. These liver tissues were analyzed for gene<br />

expressions by real-time detection PCR (RTD-PCR) and immunohistochemistry.[Results]Hepatocyte<br />

steatosis was observed<br />

from 1 week after initiation of HF-AT feeding, not accompanied<br />

with infiltration of inflammatory cells until 4 week. On week 4,<br />

Gr-1+ inflammatory cells were initially found to be infiltrated<br />

into the portal area and had continuously increased with time<br />

until week 12. TNF-α gene expression of the liver tissue was<br />

also increased consistently with increase of hepatic infiltration<br />

of Gr-1+ cells. Obvious fibrosis had been observed since<br />

week 8. After 8 week, liver fibrosis was extended, and gene<br />

expressions of albumin and type IVa collagen was decreased<br />

and increased, respectively. When ADSCs were injected into<br />

NASH mice, the fibrosis area was less extended on week 12<br />

than that of PBS injection mice group. RTD-PCR analysis of<br />

hepatic tissue showed the substantial maintained albumin gene<br />

expression (p=0.04) and the significant decrease level of Collagena<br />

(p=0.04) and TNFα(p=0.04) gene expressions, which<br />

suggested that ADSC improved protein production, suppressing<br />

fibrosis progression, and hepatic inflammation.[Conclusion]<br />

ADSC treatment prevented pathological progression of liver<br />

fibrosis with persisting hepatic inflammation, and prevented the<br />

decrease of albumin production of the liver during early phase<br />

of NASH development. ADSC treatment is considered to be<br />

preventively and therapeutically efficacious in part to NASH.<br />

Disclosures:<br />

Shuichi Kaneko - Grant/Research Support: MDS, Co., Inc, Chugai Pharma., Co.,<br />

Inc, Toray Co., Inc, Daiichi Sankyo., Co., Inc, Dainippon Sumitomo, Co., Inc,<br />

Ajinomoto Co., Inc, Bristol Myers Squibb., Inc, Pfizer., Co., Inc, Astellas., Inc,<br />

Takeda., Co., Inc, Otsuka„ÄÄPharmaceutical, Co., Inc, Eizai Co., Inc, Bayer<br />

Japan, Eli lilly Japan<br />

The following authors have nothing to disclose: Masatoshi Yamato, Yoshio Sakai,<br />

Hatsune Mochida, Akihiro Seki, Kosuke Ishida, Masao Honda<br />

948<br />

High and Low Capacity Runner (HCR and LCR) rat lines<br />

do not display significant differences in NASH phenotype<br />

when fed a fast food diet<br />

Howard C. Masuoka 1,3 , Oscar Cummings 2 , Naga P. Chalasani 1,3 ,<br />

Lawrence Lumeng 1 ; 1 Medicine, Division of Digestive and Liver DIsorders,<br />

Indiana University, Indianapolis, IN; 2 Pathology and Laboratory<br />

Medicine, Indiana University, Indianapolis, IN; 3 Cellular<br />

and Integrative Physiology, Indiana University, Indianapolis, IN<br />

Exercise and dietary changes are cornerstones of treatment<br />

of non-alcoholic fatty liver disease (NAFLD) including non-alcoholic<br />

steatohepatitis (NASH). Sedentary lifestyle is felt to<br />

predispose individuals to NAFLD/NASH, and improved cardiorespiratory<br />

fitness is associated with lower hepatic steatosis.<br />

High and Low Capacity Runner (HCR and LCR) are established,<br />

extensively phenotyped rat lines generated by selective breeding<br />

for contrasting extremes in maximum aerobic-exercise<br />

capacity (MAC). Relative to the HCR, LCR rats exhibit greater<br />

visceral adiposity, insulin resistance, and levels of circulating<br />

pro-inflammatory hormones but lower home cage activity, and<br />

non-exercise activity thermogenesis. We hypothesized that LCR<br />

rats will display increased features of NASH relatively to HCR<br />

rats when fed a “fast food” (FF) diet high in saturated fat,<br />

cholesterol and fructose. In mice this diet better recapitulates<br />

features of human NASH compared to a high fat diet. We had<br />

custom formulated a FF diet containing a caloric density of 4.61<br />

kcal/gram with a caloric composition of 44.9% fat, 15.1%<br />

protein, and 39.9% carbohydrates. The diet was nutritionally<br />

complete, and contained 30% fructose, 14% lard, 8% coconut<br />

oil, and 2% cholesterol. For 16 weeks 10 LCR and 10 HCR<br />

male rats were fed the FF diet ad libitum. Fasting weights were<br />

obtained weekly. Fasting serum ALT, glucose and insulin were<br />

measured every 4 weeks. MRI images were obtained monthly<br />

to determine adipose, lean, and fluid mass. As expected, LCR<br />

rats gained significantly more weight than HCR rats (P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!